Tags

Reading the primary literature properly: estimands, intention-to-treat versus per-protocol, confidence intervals, absolute versus relative effects, and why…

Testing at the batch or lot level: sampling plans, how many vials from a lot need testing to say anything about the lot, and the difference between a batch…

The chemistry of peptide degradation: deamidation, oxidation, hydrolysis, aggregation and fibrillation, and how temperature, pH, ionic strength, agitation and…

The arithmetic itself: milligrams to millilitres to insulin units, concentration after reconstitution, dose per draw, and vial-days per vial. Show your…

Purity as chromatographic area per cent - the fraction of detected material that is your target peak. It says nothing about how much material is in the vial,…

Certificates of analysis: what fields a useful one carries, how to tell a real analytical report from a marketing document, batch and lot traceability, and…

Storage conditions and their evidence base: minus twenty degrees for powder, refrigerated for solution, protection from light, and what the published…

Keeping material within a temperature window from manufacture to use: phase-change packs versus dry ice, thermal mass, transit-lane temperature exposure, and…

Reverse-phase high-performance liquid chromatography, the workhorse purity method. Column chemistry, mobile-phase choice, gradient slope, detection…

Reducing avoidable risk where a decision has already been made: independent verification before use, sterility practice, dose arithmetic checked twice,…

Stepwise dose increases over weeks, why the label schedules exist at all, and what tolerability-driven deviation from a schedule looks like in trial…

Quantified content: how many milligrams of peptide are actually in the vial, measured against a calibrated reference standard. A separate test from purity,…

Evaluating a supplier on evidence rather than reputation: testing history across batches, whether certificates are batch-specific, how failures were handled,…

Cross-border movement of research material: transit lanes and their thermal profiles, tracked versus untracked, declaration accuracy, and what happens after a…

The gastrointestinal cluster as a whole - nausea, vomiting, diarrhoea, constipation, reflux, early satiety - with trial incidence rates, dropout attributable…

A GLP-1 receptor agonist with a fatty-acid-acylated backbone and a roughly one-week half-life, marketed for type 2 diabetes and for weight management, and the…

Side-by-side comparison of suppliers on measurable axes - independently confirmed purity and content, lead time, cold-chain handling, documentation quality -…

The dominant tolerability signal in every trial of the class: incidence, timing relative to a dose step, duration, and the distinction between transient…

Taking a lyophilised vial to a solution of known concentration: choice of diluent, volume selection, how to add liquid without shearing the cake, dissolution…

Choosing how much diluent to add, which is really a question about what you want your measurement resolution to be. Larger volumes buy you readable syringe…

How long a preparation remains within specification: labelled expiry for a sealed lyophilised vial, beyond-use dating after reconstitution, and the difference…

Laboratory monitoring: which panels are worth ordering, sensible intervals, reference-range versus optimal-range arguments, and how to read a trend rather…

U-100 and U-40 insulin syringes as measuring instruments. A U-100 syringe is graduated in insulin units where 100 units equals 1 mL, so one unit is 0.01 mL -…

Cost arithmetic done honestly: cost per milligram after dead-space loss, list versus net price, comparing a multi-dose vial to a fixed-dose pen, and modelling…

Customs handling: how declarations are assessed, why a parcel sits at a facility for a week, seizure notices, and the practical difference between a hold and…

Certified reference materials and in-house standards: traceability, the certificate of the standard itself, system suitability, and why every quantitative…

Receptor-level pharmacology: GLP-1R as a class B GPCR, cAMP and PKA signalling, biased agonism, internalisation and resensitisation, and the central versus…

Lean body mass as measured rather than assumed: what DEXA, BIA and air-displacement plethysmography each actually estimate, the body-composition substudies in…

A dual GIP and GLP-1 receptor agonist. Questions here cover the SURPASS and SURMOUNT programmes, the practical differences from a pure GLP-1 agonist, dose…

Sterility as a test result rather than an adjective. Covers what a sterility test actually measures, why "sterile filtered" on a document is close to…

Water for injection containing roughly 0.9 per cent benzyl alcohol as a bacteriostatic agent. It suppresses growth in a multiple-withdrawal vial; it does not…

Lipid response on treatment: triglycerides, LDL-C, non-HDL-C, ApoB and Lp(a), which of them move with weight loss, and why a fasting panel drawn during rapid…

Cardiovascular outcomes: the SELECT major-adverse-event result, SOUL, SUSTAIN 6 and REWIND, how to convert a hazard ratio into an absolute risk reduction, and…

The volume trapped in the syringe hub and needle after the plunger bottoms out. It is small in absolute terms and large as a fraction of a small dose, and it…

Glycated haemoglobin as a ninety-day glycaemic average: what a change of half a point means, why it lags, and the conditions under which it misleads -…

eGFR, creatinine, cystatin C and albuminuria: the acute haemodynamic dip that is not injury, the renal outcome data from the FLOW programme, and dehydration…

Eating on a suppressed appetite: hitting nutritional targets inside a small energy budget, micronutrient risk, meal structure, and what the trial lifestyle…

What "for research use only" means as a legal and practical designation: not approved for human use, no pharmacopoeial release testing, no pharmacovigilance,…

Technique questions: angle, pinch versus flat, aspiration, injection speed, air bubbles, and the handling steps that determine whether you deliver the volume…

The decision to move up a step: what evidence supports a four-week interval, what happens when you compress it, and how trial protocols handled participants…

Counter-ion content, most often acetate or trifluoroacetate, and why it matters: the counter-ion and residual water are part of the gross mass you weighed but…

Gauge and length selection, the trade-off between draw time and tissue trauma, coring risk with larger-bore needles, and why a fixed-needle syringe behaves…

Dual-energy X-ray absorptiometry: what it measures, its precision limits, why hydration state and scan positioning move the numbers, and how to build a…

GIP receptor pharmacology, and the still-unsettled question of whether agonism or antagonism at GIPR is the metabolically useful direction. Central to any…

Enzymatic digestion followed by LC-MS/MS to confirm sequence rather than just mass. The method that catches a scrambled sequence or a D-amino-acid…

Loss of contractile tissue during energy deficit: what fraction of total loss is lean mass, why the commonly quoted figures are measurement artefacts as often…

What you can learn by looking: cake morphology, meniscus films, fibres versus stopper fragments versus true particulates, clarity after reconstitution, and…

Compounded preparations: what a 503A and a 503B facility may legally prepare and when, base versus salt forms, beyond-use dating under USP standards, and why…